The Future Is P-Tau —Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests

This Viewpoint describes the benefits and challenges offered by emerging direct-to-consumer tests for Alzheimer disease through measurement of blood levels of phosphorylated tau.

Source: JAMA Neurology - January 4, 2021 Category: Neurology Source Type: research